[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334881-105":59,"doc-detail-334881-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","unveiling-the-impact-of-mrc1-on-immune-infiltration-and-patients-prognosis-a-pan-cancer-analysis-based-on-single-cell-and-bulk-sequencing","Unveiling the Impact of MRC1 on Immune Infiltration and Patient’s Prognosis - A Pan-Cancer Analysis Based on Single-Cell and Bulk Sequencing","","MRC1, a mannose receptor C-type 1 lectin expressed in macrophages, dendritic cells, and some endothelial cells, has an unclear role in cancer. A pan-cancer study integrated TCGA, GTEx, CCLE, and single-cell datasets to quantify MRC1 expression and link it with prognosis and immune features. Results showed cancer-type dependent pro- and anti-tumor associations, broad correlations with immune infiltration and checkpoint-related parameters, and a single-cell highlight connecting MRC1 with DNA damage/repair in breast cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unveiling-the-impact-of-mrc1-on-immune-infiltration-and-patients-prognosis-a-pan-cancer-analysis-based-on-single-cell-and-bulk-sequencing/334881/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unveiling-the-impact-of-mrc1-on-immune-infiltration-and-patients-prognosis-a-pan-cancer-analysis-based-on-single-cell-and-bulk-sequencing/334881.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of analyzing MRC1 in cancers?","Question",{"text":112,"@type":113},"To clarify how MRC1 expression relates to patient prognosis, immune infiltration, and potential responsiveness to immunotherapy across multiple cancer types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets were used to evaluate MRC1 expression and immune associations?",{"text":117,"@type":113},"The study used TCGA, GTEx, CCLE, and single-cell datasets to assess expression patterns and connect MRC1 with immune-related indicators and checkpoint molecules.",{"name":119,"@type":110,"acceptedAnswer":120},"How did MRC1 relate to outcomes across different cancers?",{"text":121,"@type":113},"High MRC1 levels correlated with worse outcomes in six cancers, while improving prognosis in some cancers such as glioblastoma multiforme, indicating cancer-type dependent effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334881,1790688542,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","International Journal of General Medicine Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article ORIGINAL RESEARCH  \nUnveiling the Impact of MRC1 on Immune Infiltration and Patient’s Prognosis: A Pan-Cancer Analysis Based on Single-Cell and Bulk Sequencing  \nZhiwei Wu, Changhao Huang  \nDepartment of Organ Transplantation, XiangYa Hospital of Central South University, Changsha, People’s Republic of China Correspondence: Changhao Huang, [Email Chhuang@csu.edu.cn](Email Chhuang@csu.edu.cn)  \n\n| Purpose: Mannose receptor C-type 1 (MRC1) is an endocytic lectin receptor primarily expressed in macrophages, dendritic cells, and some endothelial cells. However, the role of MRC1 in cancers remains unclear.\u003Cbr>Methods: We analyzed MRC1 expression using The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Cancer Cell Line Encyclopedia (CCLE), and single-cell datasets. We systematically explored the prognostic implications and diagnostic value of MRC1 . Immune-related indicators, including immune cells, immune scores, and immune checkpoint molecules, were used to estimate their correlation with MRC1 expression. Finally, we explored its potential ties to immunotherapy success markers such as tumor mutation burden and DNA repair genes.\u003Cbr>Results: MRC1 showed both pro- and anti-tumor leanings depending on the cancer types. High levels correlated with poorer outcomes in six cancers but improved prognosis in some cancers like glioblastoma multiforme. This trend extended to the immune arena, where MRC1 intertwined with diverse immune parameters, suggesting its influence on affecting the tumor’s immunological landscape. Intriguingly, its expression positively associated with factors favoring immunotherapy efficacy while negatively correlating with some potential barriers. Single-cell analysis pinpointed a specific link between MRC1 and DNA damage/repair pathways in breast cancer.\u003Cbr>Conclusion: Our study provides a comprehensive landscape of MRC1 levels and diverse regulatory patterns in different cancers, deepening the understanding of MRC1’s roles in tumorigenesis and immunity.\u003Cbr>Keywords: MRC1, biomarker, immunotherapy, single-cell, pan-cancer analysis |\n| --- |\n| Introduction\u003Cbr>Immune checkpoint inhibitor (ICI) treatment, including monoclonal antibodies targeting programmed death-ligand 1, programmed death 1, and CTL-associated protein 4, is widely used to treat advanced cancer. However, many cancers do not respond to existing ICIs. Some patients with cancers considered to respond well to ICIs may not benefit from immunotherapy. In recent years, predictive biomarkers have been proposed to distinguish whether tumors are responsive to ICI treatment. Some of these markers, such as tumor mutation burden (TMB) and tumor-infiltrating lymphocytes (TILs), have been successfully applied in some tumor immunotherapy responsiveness predictions.1–3 Nevertheless, due to the heterogeneity of tumors, these biomarkers can only be used in limited cancer types. The identification of more precise biomarkers of ICI treatment through pan-cancer analysis will promote the progression of immunotherapy research.\u003Cbr>Antigen presentation is a crucial process in cellular immunity. The macrophage mannose receptor (mannose receptor C-type 1, MRC1, or CD206) plays an important role in antigen presentation and the induction of immune response.4 MRC1 is an endocytic lectin receptor expressed primarily in macrophages, dendritic cells, and some endothelial cells. A previous study demonstrated that MRC1 promotes the activation of tumor antigen-specific CD4+ and CD8+ T cell.5 Another study revealed that using a peptide conjugated to an antibody against MRC1 could reduce cross-presentation.6 |\n\nReceived: 24 January 2024  \nAccepted: 20 May 2024  \nPublished: 4 June 2024  \nInternational Journal of General Medicine 2024:17 2575–2592 2575  \n© 2024 Wu and Huang. This work is published and licensed by Dove Medical Press Limited. The f","cbCaikaT9dXzByJq","https://ap.wps.com/l/cbCaikaT9dXzByJq","pdf",18866445,18,"English","# Introduction\n# Methods\n## Gene Expression Datasets","[{\"question\":\"What was the main purpose of analyzing MRC1 in cancers?\",\"answer\":\"To clarify how MRC1 expression relates to patient prognosis, immune infiltration, and potential responsiveness to immunotherapy across multiple cancer types.\"},{\"question\":\"Which datasets were used to evaluate MRC1 expression and immune associations?\",\"answer\":\"The study used TCGA, GTEx, CCLE, and single-cell datasets to assess expression patterns and connect MRC1 with immune-related indicators and checkpoint molecules.\"},{\"question\":\"How did MRC1 relate to outcomes across different cancers?\",\"answer\":\"High MRC1 levels correlated with worse outcomes in six cancers, while improving prognosis in some cancers such as glioblastoma multiforme, indicating cancer-type dependent effects.\"}]","Unveiling the Impact of MRC1 on Immune Infiltration and Patient’s Prognosis - A Pan-Cancer Analysis Based on Single-Cell and Bulk Sequencing | PDF",1790008732,45]